ExeGi leverages the growing advances in the field of the microbiome science to deliver novel, clinically supported, live biotherapeutic and probiotic treatments for a wide variety of unmet medical needs. We offer a high-potency probiotic medical food, Visbiome™, consisting of eight strains of live, freeze-dried lactic acid bacteria.  Visbiome is specially formulated for the dietary management of dysbiosis associated with IBS, ulcerative colitis, pouchitis, and hepatic encephalopathy. Visbiome is a non-drug therapy that addresses distinct nutritional requirements, to promote microbial balance, in people with IBS, ulcerative colitis, pouchitis, and hepatic encephalopathy that cannot be addressed by the modification of the diet alone. Visbiome is currently the subject of eight clinical trials, as a medical food, in several new disease states including HIV, autism spectrum disorders, and liver cirrhosis. Visbiome is intended to be used under the supervision of a physician.